hVIVO (LON:HVO) Trading Down 6.8% – Time to Sell?

hVIVO plc (LON:HVO)’s stock price was down 6.8% during trading on Thursday . The stock traded as low as GBX 19 ($0.24) and last traded at GBX 19.10 ($0.24). Approximately 2,518,262 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 3,389,765 shares. The stock had previously closed at GBX 20.50 ($0.26).

hVIVO Price Performance

The company has a current ratio of 1.61, a quick ratio of 1.16 and a debt-to-equity ratio of 33.86. The firm’s 50-day moving average price is GBX 23.58 and its two-hundred day moving average price is GBX 26.77. The stock has a market cap of £129.95 million, a PE ratio of 636.67 and a beta of 0.97.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.